Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines

PURPOSE: Current direct-acting antiviral agents for treatment of hepatitis C virus genotype 4a (HCV-4a) have been reported to cause adverse effects, and therefore less toxic antivirals are needed. This study investigated the role of curcumin chitosan (CuCs) nanocomposite as a potential anti-HCV-4a a...

Descripción completa

Detalles Bibliográficos
Autores principales: Loutfy, Samah A, Elberry, Mostafa H, Farroh, Khaled Yehia, Mohamed, Hossam Taha, Mohamed, Aya A, Mohamed, ElChaimaa B, Faraag, Ahmed Hassan Ibrahim, Mousa, Shaker A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184126/
https://www.ncbi.nlm.nih.gov/pubmed/32368050
http://dx.doi.org/10.2147/IJN.S241702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184126/
https://www.ncbi.nlm.nih.gov/pubmed/32368050
http://dx.doi.org/10.2147/IJN.S241702

Ejemplares similares